Promising Biotechnological Approach Significantly Reduces the Cost of Key Anticancer Drug
The Kampranis Research Team, at the University of Copenhagen—a Twin4Promis advanced partner—has made a significant step toward suggesting a way to lower the cost and environmental impact of producing paclitaxel (Taxol), a widely used chemotherapy drug for cancers such as breast, ovarian, and lung cancer. Paclitaxel is a complex naturally-derived compound from the Pacific yew…
Read article